Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed Announces 13 Principles For Direct-To-Consumer Advertising

This article was originally published in The Gray Sheet

Executive Summary

Device industry trade group AdvaMed says its new set of 13 direct-to-consumer advertising principles has the broad consensus of its members and goes well beyond requirements already imposed by FDA

You may also be interested in...



Senate Explores Restrictions On Direct-To-Consumer Device Ads

Senate Special Committee on Aging Chairman Herb Kohl, D-Wis., is considering legislation to restrict direct-to-consumer advertising of medical devices

Cardiologists Critique Consumer TV Advertising For Interventional Devices

Direct-to-consumer television advertising of surgical devices raises more troubling questions than do many prominent pharmaceutical DTC ads, two cardiologists argue in an article posted on the New England Journal of Medicine Web site last week

Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval

The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel